VR Logo

Shilpa Medicare: Intimation U/R 30 Of The SEBI(LODR) Regulations- Reg

Shilpa Pharma Inc. a U.S operating company of Shilpa Medicare Limited (Shilpa) filed patent infringement lawsuit against Novartis Pharmaceutical Corporation in the United States District court for the district of Delaware seeking relief for the infringement of the US Patent No. 9 266 816 entitled Fingolimod Polymorph and Their Processes.

Click here to view PDF